BACKGROUNDUterine Artery Embolization is an Interventional Radiology technique involving placement of a catheter and injection of an embolizing agent in the uterine artery. It has now become an accepted option for the treatment of symptomatic fibroids and other gynaecological conditions. This study seeks to report the different indications and outcomes of uterine artery embolization for variety of gynaecological and obstetrical conditions. METHODS 30 women who presented for uterine artery embolization in a tertiary care teaching hospital in eastern India from June 2016 to May 2017 were retrospectively studied with follow-up up to 12 months for indications, success rate and complications. RESULTSTechnical success rate was achieved in 96.67% of cases. The most common indication for embolization was uterine fibroids. Mean reduction of fibroid volume was 51.7% at 6 weeks, 67.9% at 6 months. Most common complaint following embolization was pelvic pain, which could be managed conservatively. CONCLUSIONSUterine artery embolization is a safe and effective minimally invasive technique which can be used to manage different obstetrical and gynaecological conditions with high technical success rate and minimal complications. It is also a minimally invasive, uterus sparing treatment option in patients willing to preserve their fertility. HOW TO CITE THIS ARTICLE: MukherjeeA, Bhattacharyya B, Chakrabarty R, et al. Uterine artery embolization: different indications and outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.